Analysis Of Income And Expense [Abstract]

Optomed Oyj - Filing #2177081

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
14 660 EUR
14 850 EUR
Material income and expense [abstract]
Finance income (cost)
454,000 EUR
453,000 EUR
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense
8 827 EUR
8 702 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss
3 145 EUR
2 778 EUR
Other expenses, by nature
3 193 EUR
3 858 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
139,000 EUR
139,000 EUR
253,000 EUR
253,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
5 333 EUR
5 472 EUR
139,000 EUR
253,000 EUR
4 502 EUR
4 249 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
5 333 EUR
4 502 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.